Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
England and Wales could see drink-driving limit fall to 50mg if same measure proves successful in Scotland, minister suggests.
Aaren O'Connor, 25, did not know she had been shot and kept telling dad David "my head hurts" before becoming incoherent.
Britons are shunning trips to Disneyland Paris following the November terror attacks in the French capital.